Karen Richards
Conseiller Juridique Général chez Singulex, Inc.
Profil
Karen Richards is currently working as VP-Regulatory Affairs & Quality Assurance at Singulex, Inc. and as Senior Vice President at Precision For Medicine, Inc. She is also an Advisor at Avestria Ventures Management, LLC.
In the past, she worked as Senior Director at Novartis Vaccines & Diagnostics Ltd.
and as Principal at Beckman Coulter, Inc. and Tethys Bioscience, Inc. Ms. Richards completed her undergraduate degree from the University of California, Santa Cruz.
Postes actifs de Karen Richards
| Sociétés | Poste | Début |
|---|---|---|
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Conseiller Juridique Général | 01/09/2012 |
Avestria Ventures Management, LLC
 Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
Precision For Medicine, Inc.
 Precision For Medicine, Inc. Pharmaceuticals: MajorHealth Technology Precision For Medicine, Inc. provides clinical research focusing on genomics, immune-response assays, global specimen logistics, and biomaker analytics. The company was founded by Ethan D. Leder and Mark P. Clein in 2012 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | 01/07/2016 |
Anciens postes connus de Karen Richards
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Vaccines & Diagnostics Ltd.
 Novartis Vaccines & Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Vaccines & Diagnostics Ltd. is a healthcare company based in Liverpool, UK that provides solutions to address the evolving needs of patients worldwide. The British company offers information and resources for healthcare professionals about Novartis medicines through the Novartis HCP Portal. Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG, one of the largest pharmaceutical companies in the world. Novartis is one of Liverpool's leading employers in the healthcare industry and has a strong history of investing in the city over the last sixty years. | Directeur/Membre du Conseil | 02/01/2010 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | - |
Tethys Bioscience, Inc.
 Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Corporate Officer/Principal | - |
Formation de Karen Richards
| University of California, Santa Cruz | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Health Technology |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Finance |
Precision For Medicine, Inc.
Precision For Medicine, Inc. Pharmaceuticals: MajorHealth Technology Precision For Medicine, Inc. provides clinical research focusing on genomics, immune-response assays, global specimen logistics, and biomaker analytics. The company was founded by Ethan D. Leder and Mark P. Clein in 2012 and is headquartered in Chevy Chase, MD. | Health Technology |
Novartis Vaccines & Diagnostics Ltd.
Novartis Vaccines & Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Vaccines & Diagnostics Ltd. is a healthcare company based in Liverpool, UK that provides solutions to address the evolving needs of patients worldwide. The British company offers information and resources for healthcare professionals about Novartis medicines through the Novartis HCP Portal. Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG, one of the largest pharmaceutical companies in the world. Novartis is one of Liverpool's leading employers in the healthcare industry and has a strong history of investing in the city over the last sixty years. | Health Technology |